LilieLLinMD

Clinical Trials

• Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer Start of enrollment: 2005 Jan 01

  Completed

  Not Applicable

• Bowman-Birk Inhibitor Concentrate in Healthy Men Start of enrollment: 2007 Jun 01

  Completed

  Phase 1

• Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer Start of enrollment: 2008 May 01

  Terminated

  Not Applicable

• Yoga for Breast Cancer Start of enrollment: 2013 Mar 01

  Completed

  Not Applicable

• F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer Start of enrollment: 2011 Mar 01

  Completed

  Not Applicable

• Suitability of DCE-MRI for Detection of Vascular Changes After VBT Start of enrollment: 2013 Oct 01

  Completed

  Not Applicable

• [18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers Start of enrollment: 2014 Feb 01

  Completed

• Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology Start of enrollment: 2016 Apr 01

  Completed

• Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Start of enrollment: 2018 Jul 18

  Completed

  Phase 1

• Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF Start of enrollment: 2018 Dec 18

  Recruiting

  Phase 1

• Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers Start of enrollment: 2019 Sep 26

  Recruiting

  Phase 1

• Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery Start of enrollment: 2020 Aug 07

  Recruiting

  Phase 1

• A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer Start of enrollment: 2023 Feb 27

  Suspended

  Phase 2

  Roles: Principal Investigator, Contact

• Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors Start of enrollment: 2020 Jan 09

  Active, not recruiting

  Roles: Principal Investigator, Contact

• Join now to see all